• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diabetes Metab Res Rev . Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes

tetano

Editor, Senior Moderator
Diabetes Metab Res Rev


. 2020 Jul 19;e3388.
doi: 10.1002/dmrr.3388. Online ahead of print.
Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes


Abdallah Al-Salameh[SUP] 1 2 [/SUP], Jean-Philippe Lanoix[SUP] 3 [/SUP], Youssef Bennis[SUP] 4 [/SUP], Claire Andrejak[SUP] 5 [/SUP], Etienne Brochot[SUP] 6 [/SUP], Guillaume Deschasse[SUP] 7 [/SUP], Herv? Dupont[SUP] 8 [/SUP], Vincent Goeb[SUP] 9 [/SUP], Mait? Jaureguy[SUP] 10 [/SUP], Sylvie Lion[SUP] 11 [/SUP], Julien Maizel[SUP] 12 [/SUP], Julien Moyet[SUP] 8 [/SUP], Benoit Vaysse[SUP] 13 [/SUP], Rachel Desailloud[SUP] 1 2 [/SUP], Olivier Ganry[SUP] 14 [/SUP], Jean-Luc Schmit[SUP] 3 [/SUP], Jean-Daniel Lalau[SUP] 1 2 [/SUP]



Affiliations

Abstract

Aims: Coronavirus disease 2019 (COVID-19) is a rapidly progressing pandemic, with four million confirmed cases and 280,000 deaths at the time of writing. Some studies have suggested that diabetes is associated with a greater risk of developing severe forms of COVID-19. The primary objective of the present study was to compare the clinical features and outcomes in hospitalized COVID-19 patients with vs. without diabetes.
Methods: All consecutive adult patients admitted to Amiens University Hospital (Amiens, France) with confirmed COVID-19 up until April 21[SUP]st[/SUP] , 2020, were included. The composite primary endpoint comprised admission to the intensive care unit (ICU) and death. Both components were also analyzed separately in a logistic regression analysis and a Cox proportional hazards model.
Results: A total of 433 patients (median age: 72; 238 (55%) men; diabetes: 115 (26.6%)) were included. Most of the deaths occurred in non-ICU units and among older adults. Multivariate analyses showed that diabetes was associated neither with the primary endpoint (odds ratio (OR): 1.12; 95% confidence interval (CI): 0.66-1.90) nor with mortality (hazard ratio: 0.73; 95%CI: 0.40-1.34) but was associated with ICU admission (OR: 2.06; 95%CI 1.09-3.92, p=0.027) and a longer length of hospital stay. Age was negatively associated with ICU admission and positively associated with death.
Discussion: Diabetes was prevalent in a quarter of the patients hospitalized with COVID-19; it was associated with a greater risk of ICU admission but not with a significant elevation in mortality. Further investigation of the relationship between COVID-19 severity and diabetes is warranted. This article is protected by copyright. All rights reserved.

Keywords: acute respiratory distress syndrome; coronavirus disease 2019 (COVID-19); diabetes; intensive care; mortality; outcome.
 
Back
Top Bottom